Results 211 to 220 of about 6,042 (221)

Beträchtlicher Zusatznutzen für Guselkumab

hautnah dermatologie, 2018
openaire   +1 more source

Guselkumab/ixekizumab

Reactions Weekly
openaire   +1 more source

Acitretin/Guselkumab

Reactions Weekly
openaire   +1 more source

Efficacy and safety of intravenous induction and subcutaneous maintenance therapy with guselkumab for patients with Crohn's disease (GALAXI-2 and GALAXI-3): 48-week results from two phase 3, randomised, placebo and active comparator-controlled, double-blind, triple-dummy trials

Lancet, The
exaly  

Atezolizumab/guselkumab

Reactions Weekly
openaire   +1 more source

Brodalumab/guselkumab/risankizumab

Reactions Weekly
openaire   +1 more source

Brodalumab/Guselkumab/Ustekinumab

Reactions Weekly
openaire   +1 more source

Efficacy and safety of 48 weeks of guselkumab for patients with Crohn's disease: maintenance results from the phase 2, randomised, double-blind GALAXI-1 trial

The Lancet Gastroenterology and Hepatology
exaly  

Etanercept/Guselkumab/Ustekinumab

Reactions Weekly
openaire   +1 more source

Guselkumab (Tremfya) for psoriasis.

The Medical letter on drugs and therapeutics, 2018
openaire   +1 more source